Eli Lilly receives positive support - Analysis - 21-11-2023

Eli Lilly and Company's stock (LLY) rose in the intraday levels, while leaning on the support of the 50-day SMA, lending the stock positive momentum, amid the dominance of the main upward trend in the short term, with positive signals from the RSI, after managing to vent off its overbought saturation.

Therefore we expect more gains for the stock, targeting the pivotal resistance of 630.00, provided the support of 557.40 holds on.

Expected trend for today: Bullish